| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163238691P | 2021-08-30 | 2021-08-30 | |
| US202163238694P | 2021-08-30 | 2021-08-30 | |
| US202163282906P | 2021-11-24 | 2021-11-24 | |
| US202163283132P | 2021-11-24 | 2021-11-24 | |
| US202263393205P | 2022-07-28 | 2022-07-28 | |
| US202263393206P | 2022-07-28 | 2022-07-28 | |
| PCT/US2022/075684WO2023034812A1 (en) | 2021-08-30 | 2022-08-30 | Compounds and methods for modulating splicing |
| Publication Number | Publication Date |
|---|---|
| MX2024002558Atrue MX2024002558A (en) | 2024-04-30 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2024002558AMX2024002558A (en) | 2021-08-30 | 2022-08-30 | COMPOUNDS AND METHODS FOR MODULAR SPLICING. |
| Country | Link |
|---|---|
| US (1) | US20250154169A1 (en) |
| EP (1) | EP4395892A1 (en) |
| JP (1) | JP2024532424A (en) |
| KR (1) | KR20240096913A (en) |
| AU (1) | AU2022340791A1 (en) |
| CA (1) | CA3230277A1 (en) |
| CL (1) | CL2024000634A1 (en) |
| CO (1) | CO2024002648A2 (en) |
| CR (1) | CR20240112A (en) |
| EC (1) | ECSP24016785A (en) |
| IL (1) | IL311135A (en) |
| MX (1) | MX2024002558A (en) |
| PE (1) | PE20251687A1 (en) |
| TW (1) | TW202319047A (en) |
| WO (1) | WO2023034812A1 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024182778A1 (en)* | 2023-03-01 | 2024-09-06 | Remix Therapeutics Inc. | Compounds and methods for modulating splicing |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200808325A (en)* | 2006-07-06 | 2008-02-16 | Astrazeneca Ab | Novel compounds |
| WO2008040951A1 (en)* | 2006-10-03 | 2008-04-10 | Astrazeneca Ab | Compounds |
| CN102020643A (en)* | 2009-09-22 | 2011-04-20 | 上海恒瑞医药有限公司 | dihydropteridine ketone derivative, and preparation method and medicinal application thereof |
| CN119528903A (en) | 2012-02-10 | 2025-02-28 | Ptc医疗公司 | Compounds for the treatment of spinal muscular atrophy |
| US8729263B2 (en) | 2012-08-13 | 2014-05-20 | Novartis Ag | 1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions |
| EP3256126B1 (en) | 2015-02-09 | 2024-03-27 | F. Hoffmann-La Roche AG | Compounds for the treatment of cancer |
| WO2016169504A1 (en)* | 2015-04-24 | 2016-10-27 | 广州再极医药科技有限公司 | Condensed-ring pyrimidylamino derivative, preparation method therefor, and intermediate, pharmaceutical composition and applications thereof |
| EP3310169B1 (en) | 2015-05-30 | 2023-05-17 | PTC Therapeutics, Inc. | Methods for modulating rna splicing |
| PT3386511T (en) | 2015-12-10 | 2021-07-14 | Ptc Therapeutics Inc | Methods for treating huntington's disease |
| JP2019535789A (en) | 2016-11-28 | 2019-12-12 | ピーティーシー セラピューティクス，インコーポレーテッド | Methods for modulating RNA splicing |
| BR112019026508A2 (en) | 2017-06-14 | 2020-07-14 | Ptc Therapeutics, Inc. | methods for modifying rna splicing |
| WO2019028440A1 (en) | 2017-08-04 | 2019-02-07 | Skyhawk Therapeutics, Inc. | Methods and compositions for modulating splicing |
| JP7195328B2 (en) | 2017-09-25 | 2022-12-23 | スカイホーク・セラピューティクス・インコーポレーテッド | Methods and compositions for screening and identifying splicing modulators |
| KR20200142039A (en) | 2018-04-10 | 2020-12-21 | 스카이호크 테라퓨틱스, 인코포레이티드 | Compounds for cancer treatment |
| CR20220484A (en) | 2020-02-28 | 2022-12-15 | Remix Therapeutics Inc | Heterocyclic amides and their use for modulating splicing |
| Publication number | Publication date |
|---|---|
| KR20240096913A (en) | 2024-06-26 |
| JP2024532424A (en) | 2024-09-05 |
| PE20251687A1 (en) | 2025-07-02 |
| CO2024002648A2 (en) | 2024-05-30 |
| CA3230277A1 (en) | 2023-03-09 |
| TW202319047A (en) | 2023-05-16 |
| AU2022340791A1 (en) | 2024-03-14 |
| IL311135A (en) | 2024-04-01 |
| US20250154169A1 (en) | 2025-05-15 |
| CL2024000634A1 (en) | 2024-07-12 |
| CR20240112A (en) | 2024-08-07 |
| EP4395892A1 (en) | 2024-07-10 |
| WO2023034812A1 (en) | 2023-03-09 |
| ECSP24016785A (en) | 2024-05-31 |
| Publication | Publication Date | Title |
|---|---|---|
| MX2022010683A (en) | Compounds and methods for modulating splicing. | |
| MX2022012678A (en) | Compounds and methods for modulating splicing. | |
| MX2022012676A (en) | Compounds and methods for modulating splicing. | |
| DK3873903T3 (en) | SUBSTITUTED 6-AZABENZIMIDAZOLE COMPOUNDS AS HPK1 INHIBITORS | |
| BR112022017089A2 (en) | PYRIDAZINE DERIVATIVES TO MODULATE NUCLEIC ACID SPLICING | |
| MX2019011090A (en) | Herbicidal mixture, composition and method. | |
| MX2018000394A (en) | ARYLOXIPIRIMIDINILIC ETERS AS HERBICIDES. | |
| MX2022010681A (en) | Compounds and methods for modulating splicing. | |
| CL2019003324A1 (en) | Salts and solid forms of a monobactam antibiotic. (divisional request 201800745) | |
| CL2021003373A1 (en) | New egfr inhibitors | |
| EA201691799A1 (en) | BICYCLIC COMPOUNDS AS AUTOTAXIN PRODUCT INHIBITORS (ATX) AND LYSOPHOSPHATIDYLIC ACID INHIBITORS (LPA) | |
| DOP2025000200A (en) | COMPOUNDS AND METHODS FOR MODULATING RAS-PI3K | |
| MX2024002558A (en) | COMPOUNDS AND METHODS FOR MODULAR SPLICING. | |
| MX2024002554A (en) | COMPOUNDS AND METHODS FOR MODULATING THE SPLICING. | |
| MX389097B (en) | HIGHLY EFFECTIVE STABILIZER. | |
| CR20220483A (en) | Compounds and methods for modulating splicing | |
| EA202192237A1 (en) | CRYSTALLINE FORMS OF THE JAK2 INHIBITOR | |
| WO2024182747A3 (en) | Compounds and methods for modulating splicing | |
| DOP2017000036A (en) | AZETIDINYLOXYPHENYLPIRROLIDINE COMPOUNDS | |
| ECSP11010817A (en) | ANTIFUNGAL AGENTS |